264 related articles for article (PubMed ID: 23212076)
1. Dual roles of PKM2 in cancer metabolism.
Wu S; Le H
Acta Biochim Biophys Sin (Shanghai); 2013 Jan; 45(1):27-35. PubMed ID: 23212076
[TBL] [Abstract][Full Text] [Related]
2. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
Chaneton B; Gottlieb E
Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
[TBL] [Abstract][Full Text] [Related]
3. The multifaceted regulation and functions of PKM2 in tumor progression.
Li Z; Yang P; Li Z
Biochim Biophys Acta; 2014 Dec; 1846(2):285-96. PubMed ID: 25064846
[TBL] [Abstract][Full Text] [Related]
4. PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation.
Li T; Han J; Jia L; Hu X; Chen L; Wang Y
Protein Cell; 2019 Aug; 10(8):583-594. PubMed ID: 30887444
[TBL] [Abstract][Full Text] [Related]
5. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.
Zheng S; Liu Q; Liu T; Lu X
J Physiol Biochem; 2021 Aug; 77(3):355-363. PubMed ID: 33835423
[TBL] [Abstract][Full Text] [Related]
6. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
Li S; Ji X; Wang R; Miao Y
Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
[TBL] [Abstract][Full Text] [Related]
7. PKM2 contributes to cancer metabolism.
Wong N; Ojo D; Yan J; Tang D
Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of PKM2 in cell metabolism and cancer progression.
Luo W; Semenza GL
Trends Endocrinol Metab; 2012 Nov; 23(11):560-6. PubMed ID: 22824010
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
Mazurek S
Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.
Tamada M; Suematsu M; Saya H
Clin Cancer Res; 2012 Oct; 18(20):5554-61. PubMed ID: 23071357
[TBL] [Abstract][Full Text] [Related]
11. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
Yacovan A; Ozeri R; Kehat T; Mirilashvili S; Sherman D; Aizikovich A; Shitrit A; Ben-Zeev E; Schutz N; Bohana-Kashtan O; Konson A; Behar V; Becker OM
Bioorg Med Chem Lett; 2012 Oct; 22(20):6460-8. PubMed ID: 22963766
[TBL] [Abstract][Full Text] [Related]
12. Activators of PKM2 in cancer metabolism.
Warner SL; Carpenter KJ; Bearss DJ
Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
[TBL] [Abstract][Full Text] [Related]
13. Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target.
van Niekerk G; Engelbrecht AM
Cell Oncol (Dordr); 2018 Aug; 41(4):343-351. PubMed ID: 29797241
[TBL] [Abstract][Full Text] [Related]
14. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.
Chen Z; Wang Z; Guo W; Zhang Z; Zhao F; Zhao Y; Jia D; Ding J; Wang H; Yao M; He X
Oncogene; 2015 Jul; 34(30):3946-56. PubMed ID: 25263439
[TBL] [Abstract][Full Text] [Related]
15. Non-metabolic functions of pyruvate kinase M2: PKM2 in tumorigenesis and therapy resistance.
İlhan M
Neoplasma; 2022 Jul; 69(4):747-754. PubMed ID: 35471978
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
He Y; Wang Y; Liu H; Xu X; He S; Tang J; Huang Y; Miao X; Wu Y; Wang Q; Cheng C
Leuk Res; 2015 Dec; 39(12):1428-36. PubMed ID: 26453405
[TBL] [Abstract][Full Text] [Related]
17. PKM2, a potential target for regulating cancer.
Li YH; Li XF; Liu JT; Wang H; Fan LL; Li J; Sun GP
Gene; 2018 Aug; 668():48-53. PubMed ID: 29775756
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2.
Chen J; Jiang Z; Wang B; Wang Y; Hu X
Cancer Lett; 2012 Mar; 316(2):204-10. PubMed ID: 22154083
[TBL] [Abstract][Full Text] [Related]
19. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells.
Zhou CF; Li XB; Sun H; Zhang B; Han YS; Jiang Y; Zhuang QL; Fang J; Wu GH
IUBMB Life; 2012 Sep; 64(9):775-82. PubMed ID: 22807066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
